It was found that both APOE and CLU could delay the initiation time of amyloid growth kinetics in a concentration-dependent manner, acting as extracellular chaperones to inhibit amyloid-β deposition in patients with sporadic cerebral amyloid angiopathy [50]. Here, APOE is linked to cerebral amyloid angiopathy.